|

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

RECRUITINGN/ASponsored by The University of Texas Health Science Center, Houston
Actively Recruiting
PhaseN/A
SponsorThe University of Texas Health Science Center, Houston
Started2025-09-18
Est. completion2028-09-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07182045

Summary

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
* Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids

Exclusion Criteria:

* Pregnancy,
* Age \<18yo,
* Patients undergoing concomitant surgery such as endometriosis surgery,
* Suspected malignancy

Conditions3

CancerMyomaSurgery

Locations1 site

Memorial Hermann Hospital
Houston, Texas, 77030
Randa Jalloul, MD713-486-7700randa.j.jalloul@uth.tmc.edu

Find trials near these locations

Cancer trials in HoustonAll trials in Texas

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.